Study Details To Evaluate the Safety and Efficacy of PAKHD in ESRD Patients
Protocol Number PAKHD2
Phase FIM
Therapeutic Area Nephrology
Subject Types With Medical Condition
Indication End-stage renal disease (ESRD)
Principal Investigator Dr Titus Lau
Investigator Product / Device PAKHD
Sponsor Nextkidney SG Pte Ltd
Top